Kestra Medical Technologies, Ltd. Common Stock KMTS Income Statement
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| $83.72M+12.7% | $74.26M+11.8% | $66.4M+11.0% | $59.82M+20.8% | $49.54M+19.7% | ||
| $42.91M+7.8% | $39.8M+6.0% | $37.54M+5.4% | $35.61M+8.3% | $32.87M+5.4% | ||
| $40.81M+18.5% | $34.46M+19.4% | $28.86M+19.2% | $24.21M+45.3% | $16.67M+63.2% | ||
| 48.8%+2.4pp | 46.4%+2.9pp | 43.5%+3.0pp | 40.5%+6.8pp | 33.6%+9.0pp | ||
| $19.24M+9.2% | $17.62M+8.4% | $16.25M+3.8% | $15.65M+10.7% | $14.14M-3.5% | ||
| $165.19M+12.9% | $146.28M+13.0% | $129.44M+12.6% | $114.94M+40.2% | $81.96M+8.3% | ||
| $184.42M+12.5% | $163.9M+12.5% | $145.69M+11.6% | $130.59M+35.9% | $96.1M+6.4% | ||
| -$143.61M-10.9% | -$129.45M-10.8% | -$116.83M-9.8% | -$106.38M-33.9% | -$79.43M+0.8% | ||
| -171.5%+2.8pp | -174.3%+1.6pp | -175.9%+1.9pp | -177.8%-17.5pp | -160.4%+33.1pp | ||
| $7.46M+1.4% | $7.36M-5.4% | $7.77M+0.5% | $7.73M+2.7% | $7.53M+3.1% | ||
| -$395K+46.5% | -$739K-760% | $112K+104% | -$2.77M-257% | -$773.75K+48.1% | ||
| -$143.68M-9.4% | -$131.29M-10.2% | -$119.16M-4.8% | -$113.68M-31.9% | -$86.19M+2.0% | ||
| $204K+9.1% | $187K+16.1% | $161K+19.3% | $135K+246% | $39K+44.4% | ||
| -$144.83M-9.6% | -$132.17M-10.4% | -$119.76M-5.2% | -$113.81M-33.4% | -$85.29M+2.3% | ||
| -173%+5.0pp | -178%+2.4pp | -180.3%+9.9pp | -190.3%-18.1pp | -172.2%+38.7pp | ||
| -$3.32+16.2% | -$3.96+12.2% | -$4.51+12.1% | -$5.13-6.3% | -$4.83+0.4% | ||
| -$135.39M-11.6% | -$121.32M-11.1% | -$109.2M-11.0% | -$98.41M-39.8% | -$70.41M-0.5% | ||
| -161.7%+1.7pp | -163.4%+1.1pp | -164.5%+0.1pp | -164.5%-22.4pp | -142.1%+27.1pp | ||
| -$143.61M-10.9% | -$129.45M-10.8% | -$116.83M-9.8% | -$106.38M-33.9% | -$79.43M+0.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Kestra Medical Technologies, Ltd. Common Stock's revenue?
- Kestra Medical Technologies, Ltd. Common Stock (KMTS) generated $83.7M in revenue over the trailing twelve months, up 69.0% year over year.
- Is Kestra Medical Technologies, Ltd. Common Stock profitable?
- Kestra Medical Technologies, Ltd. Common Stock is not currently profitable: it reported a net loss of $144.8M over the trailing twelve months, a -173.0% net margin.
- What are Kestra Medical Technologies, Ltd. Common Stock's profit margins?
- Gross margin is 48.8% and operating margin is -171.5%, with a -173.0% net margin.
- What is Kestra Medical Technologies, Ltd. Common Stock's earnings per share?
- Kestra Medical Technologies, Ltd. Common Stock's diluted EPS over the trailing twelve months is $-3.32.
- Where does Kestra Medical Technologies, Ltd. Common Stock's income statement data come from?
- Every line is extracted from Kestra Medical Technologies, Ltd. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
